214 related articles for article (PubMed ID: 26164754)
1. Dysregulated miR-103 and miR-143 expression in peripheral blood mononuclear cells from induced prediabetes and type 2 diabetes rats.
Vatandoost N; Amini M; Iraj B; Momenzadeh S; Salehi R
Gene; 2015 Nov; 572(1):95-100. PubMed ID: 26164754
[TBL] [Abstract][Full Text] [Related]
2. Significance of serum microRNAs in pre-diabetes and newly diagnosed type 2 diabetes: a clinical study.
Kong L; Zhu J; Han W; Jiang X; Xu M; Zhao Y; Dong Q; Pang Z; Guan Q; Gao L; Zhao J; Zhao L
Acta Diabetol; 2011 Mar; 48(1):61-9. PubMed ID: 20857148
[TBL] [Abstract][Full Text] [Related]
3. Peripheral blood microRNA-15a is a potential biomarker for type 2 diabetes mellitus and pre-diabetes.
Al-Kafaji G; Al-Mahroos G; Alsayed NA; Hasan ZA; Nawaz S; Bakhiet M
Mol Med Rep; 2015 Nov; 12(5):7485-90. PubMed ID: 26460159
[TBL] [Abstract][Full Text] [Related]
4. Differential expression of microRNAs in plasma of patients with prediabetes and newly diagnosed type 2 diabetes.
Yan S; Wang T; Huang S; Di Y; Huang Y; Liu X; Luo Z; Han W; An B
Acta Diabetol; 2016 Oct; 53(5):693-702. PubMed ID: 27039347
[TBL] [Abstract][Full Text] [Related]
5. Serum miR-23a, a potential biomarker for diagnosis of pre-diabetes and type 2 diabetes.
Yang Z; Chen H; Si H; Li X; Ding X; Sheng Q; Chen P; Zhang H
Acta Diabetol; 2014 Oct; 51(5):823-31. PubMed ID: 24981880
[TBL] [Abstract][Full Text] [Related]
6. Pancreas-enriched miRNAs are altered in the circulation of subjects with diabetes: a pilot cross-sectional study.
Seyhan AA; Nunez Lopez YO; Xie H; Yi F; Mathews C; Pasarica M; Pratley RE
Sci Rep; 2016 Aug; 6():31479. PubMed ID: 27558530
[TBL] [Abstract][Full Text] [Related]
7. A unique plasma microRNA profile defines type 2 diabetes progression.
de Candia P; Spinetti G; Specchia C; Sangalli E; La Sala L; Uccellatore A; Lupini S; Genovese S; Matarese G; Ceriello A
PLoS One; 2017; 12(12):e0188980. PubMed ID: 29200427
[TBL] [Abstract][Full Text] [Related]
8. Circulating MiRNAs of 'Asian Indian Phenotype' Identified in Subjects with Impaired Glucose Tolerance and Patients with Type 2 Diabetes.
Prabu P; Rome S; Sathishkumar C; Aravind S; Mahalingam B; Shanthirani CS; Gastebois C; Villard A; Mohan V; Balasubramanyam M
PLoS One; 2015; 10(5):e0128372. PubMed ID: 26020947
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-194 Modulates Glucose Metabolism and Its Skeletal Muscle Expression Is Reduced in Diabetes.
Latouche C; Natoli A; Reddy-Luthmoodoo M; Heywood SE; Armitage JA; Kingwell BA
PLoS One; 2016; 11(5):e0155108. PubMed ID: 27163678
[TBL] [Abstract][Full Text] [Related]
10. Altered levels of circulating cytokines and microRNAs in lean and obese individuals with prediabetes and type 2 diabetes.
Nunez Lopez YO; Garufi G; Seyhan AA
Mol Biosyst; 2016 Dec; 13(1):106-121. PubMed ID: 27869909
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA Expression Varies according to Glucose Tolerance, Measurement Platform, and Biological Source.
Dias S; Hemmings S; Muller C; Louw J; Pheiffer C
Biomed Res Int; 2017; 2017():1080157. PubMed ID: 28529949
[TBL] [Abstract][Full Text] [Related]
12. Circulating miR-135 May Serve as a Novel Co-biomarker of HbA1c in Type 2 Diabetes.
Monfared YK; Honardoost M; Sarookhani MR; Farzam SA
Appl Biochem Biotechnol; 2020 Jun; 191(2):623-630. PubMed ID: 31833019
[TBL] [Abstract][Full Text] [Related]
13. Plasma
Jiang Q; Lyu XM; Yuan Y; Wang L
Biosci Rep; 2017 Apr; 37(2):. PubMed ID: 28108673
[TBL] [Abstract][Full Text] [Related]
14. Comparative microRNA expression profiles of cynomolgus monkeys, rat, and human reveal that mir-182 is involved in T2D pathogenic processes.
Zhou J; Meng Y; Tian S; Chen J; Liu M; Zhuo M; Zhang Y; Du H; Wang X
J Diabetes Res; 2014; 2014():760397. PubMed ID: 25530976
[TBL] [Abstract][Full Text] [Related]
15. Comparison of Insulin Resistance and β-Cell Dysfunction Between the Young and the Elderly in Normal Glucose Tolerance and Prediabetes Population: A Prospective Study.
Chen G; Shi L; Cai L; Lin W; Huang H; Liang J; Li L; Lin L; Tang K; Chen L; Lu J; Bi Y; Wang W; Ning G; Wen J
Horm Metab Res; 2017 Feb; 49(2):135-141. PubMed ID: 27459384
[TBL] [Abstract][Full Text] [Related]
16. Circulating microRNA-21 is an early predictor of ROS-mediated damage in subjects with high risk of developing diabetes and in drug-naïve T2D.
La Sala L; Mrakic-Sposta S; Tagliabue E; Prattichizzo F; Micheloni S; Sangalli E; Specchia C; Uccellatore AC; Lupini S; Spinetti G; de Candia P; Ceriello A
Cardiovasc Diabetol; 2019 Feb; 18(1):18. PubMed ID: 30803440
[TBL] [Abstract][Full Text] [Related]
17. Swimming Exercise Induced Reversed Expression of miR-96 and Its Target Gene NaV1.3 in Diabetic Peripheral Neuropathy in Rats.
Aghdam AM; Shahabi P; Karimi-Sales E; Ghiasi R; Sadigh-Eteghad S; Mahmoudi J; Alipour MR
Chin J Physiol; 2018 Apr; 61(2):124-129. PubMed ID: 29689688
[TBL] [Abstract][Full Text] [Related]
18. Circulating miR-146a, miR-34a and miR-375 in type 2 diabetes patients, pre-diabetic and normal-glycaemic individuals in relation to β-cell function, insulin resistance and metabolic parameters.
García-Jacobo RE; Uresti-Rivera EE; Portales-Pérez DP; González-Amaro R; Lara-Ramírez EE; Enciso-Moreno JA; García-Hernández MH
Clin Exp Pharmacol Physiol; 2019 Dec; 46(12):1092-1100. PubMed ID: 31355469
[TBL] [Abstract][Full Text] [Related]
19. Alterations of miR-132 are novel diagnostic biomarkers in peripheral blood of schizophrenia patients.
Yu HC; Wu J; Zhang HX; Zhang GL; Sui J; Tong WW; Zhang XY; Nie LL; Duan JH; Zhang LR; Lv LX
Prog Neuropsychopharmacol Biol Psychiatry; 2015 Dec; 63():23-9. PubMed ID: 25985888
[TBL] [Abstract][Full Text] [Related]
20. Circulating levels and characterization of microparticles in patients with different degrees of glucose tolerance.
Giannella A; Radu CM; Franco L; Campello E; Simioni P; Avogaro A; de Kreutzenberg SV; Ceolotto G
Cardiovasc Diabetol; 2017 Sep; 16(1):118. PubMed ID: 28927403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
